CompleteSpend
One Goal. Two Paths. The Drive to Aggregate Spend Land.
Accuracy and completeness are the ultimate objectives of transparency reporting and the primary dimensions by which data quality is measured in the aggregate spend arena. With unlimited resources and unlimited time, this objective could easily be attained by most organizations; but in the transparency reporting game, the limiting factor is time.
Physician Payments Sunshine Act data collection takes effect January 1, 2012. Are you prepared?
While no one is surprised that HHS missed its October 1, 2011 deadline for publishing reporting guidelines to the healthcare industry for Physician Payments Sunshine Act reporting, the bottom line is a lack of performance on CMS’s part to provide direction to the industry should not be (and likely will not be) considered an excuse for a lack of preparedness for data collection by covered reporting entities (U.S. drug, medical device, biological or medical supply manufacturers).
Healthy Data Webinar – Check in on the checkup for the Sunshine Act
After a well-attended session at CBI's 5th Annual Tracking State Laws and Aggregate Spend , Health Market Science and CBI decided to create a follow-up webinar that echoes some points offered in my August presentation, while offering more detail on the cost of poor quality data.
Q: Is the industry ready to comply with aggregate spend regs? A: Surprisingly, maybe not.
As a speaker at the CBI Aggregate Spend Conference last week, (with a timely agenda and a great turnout) I was looking forward to gauging Life Science organizations’ response to what will soon be the final regs of the Sunshine Act. I was quickly enlightened. With the first session, I could tell participants were still learning the options for overcoming the challenges of transparency. In fact, some are still in the planning stage!
The Pharma C-Suite is under increased scrutiny from the feds. Why should it have to get personal?
The recent Associated Press article, In shift, feds target top execs for health fraud, may rattle some chains in healthcare’s C-suite. In the article, the author suggests that “Federal enforcers are targeting individual executives in health care fraud cases that used to be aimed at impersonal corporations.” The notion of holding executives accountable has grown since the economic recession.
A perspective on the hidden value of the Physician Payments Sunshine Act
When the moon is in the seventh house (Pelosi’s House, that is)
And Jupiter aligns with Mars (Congress finally passes a healthcare reform bill)
Then peace will guide the planets (peace = improved and expanded coverage dictated to the insurers)
And love will steer the stars (love for the uninsured)
Meet Aggregate Spend Challenges Head on with CompleteSpend™
Today, legislation requires Life Sciences organizations to report their spending including promotion, education, consulting, and grant per practitioner and/or facility.
Maximize Aggregate Spend Investment with High Quality and Actionable Data
Read about our proven track record in the March IDC Health Aggregate Spend Report.
Meet aggregate spend challenges head on with CompleteSpend™
Read about our proven track record in the March IDC Health Aggregate Spend Report.
This Web-based HMS solution includes built-in reporting templates designed for federal and state laws, ad hoc reporting and proactive alert—based on your organization’s business rules and our industry best practices.
Meet Aggregate Spend Challenges Head on with CompleteSpend.
Today, legislation requires Life Sciences organizations to report their spending including promotion, education, consulting, and grant per practitioner and/or facility.
Maximize Aggregate Spend Investment with High Quality and Actionable Data
Read about our proven track record in the March IDC Health Aggregate Spend Report.
